THE TAY-SACHS DISEASE FIBROBLAST MODEL: FAILURE TO RESPOND TO EXOGENOUS HEXOSAMINIDASE A
Keyword(s):
In vitro studies with Tay-Sachs disease (TSD) fibroblast cultures treated with β-D-N-acetylhexosaminidase A (Hex A) did not reveal any detectable incorporation of the enzyme into cultured cells as measured by activity against the fluorogenic substrate or intracellular radioactivity of the 125I-labeled enzyme. Futhermore, there was no demonstrable alteration of 14C-labeled GM2 (TSD) ganglioside in treated cells. It was concluded that parenteral administration of this enzyme to affected infants is not clinically justifiable.
1981 ◽
Vol 6
(3)
◽
pp. 381-388
◽
1975 ◽
Vol 142
(2)
◽
pp. 332-345
◽
Keyword(s):
1982 ◽
Vol 40
◽
pp. 210-211
Keyword(s):
1971 ◽
Vol 29
◽
pp. 556-557
Keyword(s):